Skip to main content
Equibles

Beneficial ownership — 13D / 13G

85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
T. Rowe Price Investment Management, Inc. TMS Teamshares Inc 13G 18.3% 2mo
First National Advisers, LLC GBIL Goldman Sachs ETF Trust 13G 92% 2mo
Bank of New York Mellon Corp FCAL First Trust Exchange-Traded Fund III 13G/A 0% 2mo
PRICE T ROWE ASSOCIATES INC /MD/ PRGO PERRIGO Co plc 13G/A 0.1% 2mo
PRICE T ROWE ASSOCIATES INC /MD/ VICR Vicor Corp 13G/A 12.8% 2mo
FMR LLC CRL Charles River Laboratories International, Inc. 13G/A 10.2% 2mo
1832 Asset Management L.P. OTEX Open Text Corp 13G/A 8.9% 2mo
ADAR1 Capital Management, LLC TENX Tenax Therapeutics, Inc. 13G 14% 2mo
GROUP ONE TRADING LLC POET Poet Technologies Inc. 13G/A 0.7% 2mo
FMR LLC REZI Resideo Technologies, Inc. 13G/A 11% 2mo
STATE STREET CORP LEU Centrus Energy Corp 13G 10.2% 2mo
Alger Associates, Inc. 13-3017981 ALAI Alger ETF Trust 13G/A 2.5% 2mo
ARK Investment Management LLC TWST Twist Bioscience Corp 13G/A 5.11% 2mo
PRICE T ROWE ASSOCIATES INC /MD/ IQ iQIYI, Inc. 13G/A 8.8% 2mo
First National Advisers, LLC BILZ PIMCO ETF Trust 13G 14.69% 2mo
FEDERATED HERMES, INC. FBRX Forte Biosciences, Inc. 13G/A 0% 2mo
First National Advisers, LLC AAOX Investment Managers Series Trust II 13G 23.53% 2mo
MORGAN STANLEY EVH Evolent Health, Inc. 13G/A 2.7% 2mo
WELLINGTON MANAGEMENT GROUP LLP AAON Aaon, Inc. 13G/A 10.4% 2mo
FMR LLC CVSA Covista Inc. 13G/A 10.4% 2mo
FMR LLC LEG Leggett & Platt Inc 13G/A 0% 2mo
Orbis Investment Management Limited NCMI National CineMedia, Inc. 13G/A 11.8% 2mo
GOLDMAN SACHS GROUP INC QVCAQ QVC Group, Inc. 13G/A 0% 2mo
JANUS HENDERSON GROUP PLC VOGX Vogenx, Inc. 13G 13% 2mo
FMR LLC BWX Spdr Series Trust 13G/A 12% 2mo
FMR LLC ONT Onterris, Inc. 13G 12.7% 2mo
Bank of New York Mellon Corp FCAL First Trust Exchange-Traded Fund III 13G/A 0% 2mo
PRICE T ROWE ASSOCIATES INC /MD/ TXG 10x Genomics, Inc. 13G 11.7% 2mo
FMR LLC SUNC SunocoCorp LLC 13G/A 10.9% 2mo
PRICE T ROWE ASSOCIATES INC /MD/ KYMR Kymera Therapeutics, Inc. 13G/A 10.7% 2mo
FMR LLC ORLA Orla Mining Ltd. 13G/A 0% 2mo
FMR LLC BLBD Blue Bird Corp 13G/A 10.2% 2mo
FMR LLC LXFR Luxfer Holdings PLC 13G/A 3.7% 2mo
WELLINGTON MANAGEMENT GROUP LLP ZBIO Zenas BioPharma, Inc. 13G 10.1% 2mo
First National Advisers, LLC ALLW SSGA Active Trust 13G 8.6% 2mo
WELLINGTON MANAGEMENT GROUP LLP TPG TPG Inc. 13G/A 11.2% 2mo
InnoCare Pharma Inc. ZBIO Zenas BioPharma, Inc. 13G/A 10.4% 2mo
HSBC HOLDINGS PLC AACG ATA Creativity Global 13G/A 3.7% 2mo
Dotmar Investments Ltd KORE KORE Group Holdings, Inc. 13G/A 0% 2mo
GROUP ONE TRADING LLC CATO Cato Corp 13G/A 1.4% 2mo
Frontier Nuclear & Minerals Inc. NUR Nuran Wireless Inc. 13G 9.9% 2mo
DITM HOLDINGS PTY LTD REA Rare Earths Americas, Inc. 13G 9.9% 2mo
LIBRA ADVISORS LLC BMM Blue Moon Metals Inc. 13G 6.02% 2mo
William O'Dowd IV DLPN Dolphin Entertainment, Inc. 13D 19% 2mo
LIBRA ADVISORS LLC IAUX i-80 Gold Corp. 13G 7.44% 2mo
Whitefort Capital Management, LP ABUS Arbutus Biopharma Corp 13G 8% 2mo
3i, LP VBIO Valion Bio, Inc. 13G/A 9.9% 2mo
Robert J. Fisher GAP Gap Inc 13D/A 13% 2mo
Tether Holdings Limited RUM RUM Group Inc. 13D/A 50.3% 2mo
Timothy Mark Dyer ADXN Addex Therapeutics Ltd. 13D/A 9.01% 2mo